1. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikäheimo I, Jellum E, Lehtinen M, Lenner P, Hakulinen T, Närvänen A, Pukkala E, Thoresen S, Youngman L, Paavonen J. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA. 2001;285(1):47–51.
2. Bhatla N, Puri K, Joseph E, Kriplani A, Iyer VK, Sreenivas V. Association of Chlamydia trachomatis infection with human papillomavirus (HPV) & cervical intraepithelial neoplasia—a pilot study. Indian J Med Res. 2013;137(3):533.
3. Brock KE, MacLennan R, Brinton LA, Melnick JL, Adam E, Mock PA, Berry G. Smoking and infectious agents and risk of in situ cervical cancer in Sydney. Aust Cancer Res. 1989;49(17):4925–8.
4. CDC Sexually Transmitted Diseases Surveillance 2010. Chlamydia. Atlanta, GA: US Department of Health and Human Services, CDC; 2010. http://www.cdc.gov/std/stats07/toc.htm. Last accessed on 21 July 2011.
5. Corbino N, Guglielmino S, Petrina M, Tempera G, Ciravolo L, Cianci A. The role of anti-herpes specific serum IgA levels as a marker in cervical oncogenesis. Eur J Gynaecol Oncol. 1989;10(2):103–8.